Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH) | MicrobiomeTrials← Back to trialsNCT07631637
Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-07-06Est. Completion: 2029-01-29
Enrollment target: 150 participants Locations- Adobe Clinical Research, Tucson, Arizona, United States
- The Institute for Liver Health II LLC dba Arizona Liver Health, Tucson, Arizona, United States
- Del Sol Research Management, LLC, Tucson, Arizona, United States
- California Liver Research Institute, Pasadena, California, United States
- Inland Empire Clinical Trials, Rialto, California, United States
- Universal Axon Clinical Research, Doral, Florida, United States
- Genoma Research Group, Inc., Miami, Florida, United States
- Med Research of Florida, LLC, Miami, Florida, United States
- Tandem Clinical Research, Marrero, Louisiana, United States
- Tandem Clinical Research, Metairie, Louisiana, United States
- American Research Corporation, Austin, Texas, United States
- Advanced Medical Trials, Georgetown, Texas, United States
- Pioneer Research Solutions, Inc., Houston, Texas, United States
- American Research Corporation at The Texas Liver Institute, San Antonio, Texas, United States
- Siena Research Network, Sugar Land, Texas, United States
- Fundacion de Investigacion (FDI) Clinical Research, San Juan, Puerto Rico
Other microbiome trials you might be interested in
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseMASH - Metabolic Dysfunction-Associated SteatohepatitisLiver Fibrosis/NASH
The goal of this clinical trial is to learn how physical exercise affects liver health in adults with metabolic dysfunct…
Madrid, SpainEst. completion Jun 2027
Metabolic Associated Fatty Liver DiseaseMetabolic Associated Steatotic Liver DiseaseCirrhosis, LiverNASHLiver FibrosisLiver FatLiver SteatosesLiver Inflammation
The Non-Invasive Biomarkers for Metabolic Liver Disease (NIMBLE) study is a comprehensive, multi-year collaborative effo…
Miami, United StatesEst. completion Jun 30, 2027